Augustina Isioma Ikusemoro: ABO Typing Is Not the Same in Infants and Adults
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on Linkedin:
“ABO typing is not the same in infants and adults.
And misunderstanding this can affect patient safety.
Many people assume blood grouping works the same way at every age.
In reality, biology changes the interpretation.
This visual highlights one of the most important – and often overlooked — principles in transfusion medicine:
Newborns are not small adults.
In infants:
- Only forward grouping is reliable
- Reverse grouping is often weak or absent
- Detected antibodies are usually maternal IgG
- A and B antigens may be not fully expressed yet
- Testing is often performed to investigate ABO incompatibility in neonatal jaundice
In adults:
- Both forward and reverse grouping are required
- Naturally occurring anti-A and anti-B antibodies are present
- Antigen expression is fully developed
- Results are usually strong and concordant
Understanding this difference prevents:
- misinterpretation of results
- incorrect transfusion decisions
- avoidable neonatal risk
Because safe transfusion practice begins with one principle:
Interpret the test in the context of the patient’s age.
Right test.
Right time.
Right interpretation.
Better outcomes.
Signature of Blood Doki
Educate. Empower. Elevate.”
Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:14Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell
-
Sep 2, 2026, 23:50Shashank Joshi: Individualized vs. Standard BP Control Shows Similar 90-Day Outcomes